Physician profile
Molly G Eisner
NPI 1366561029
$623.84
in general payments reported to CMS, 2019-2025
9 companies · $210 in 2025
The $210 reported for 2025 was less than what a typical Dermatology provider received nationally (typical 2025 total: $772).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $37.55 · 2021: $94.18 · 2022: $111 · 2023: $75.67 · 2024: $95.53 · 2025: $210.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $282 · Education: $99.00.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $282.33 |
| Education | $99.00 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $347.58 | 2021-2025 | |
| Janssen Biotech, INC. | $117.59 | 2022-2025 | Tremfya |
| Galderma Laboratories, L.P. | $38.32 | 2021-2025 | Nemluvio |
| Leo Pharma INC. | $28.06 | 2025 | Anzupgo |
| Merck Sharp & Dohme LLC | $25.78 | 2019 | |
| Genzyme Corporation | $22.16 | 2021 | |
| Ucb, INC. | $16.86 | 2021 | |
| Organon LLC | $15.72 | 2024 | |
| Ortho Dermatologics, A Division of Bausch Health US, LLC | $11.77 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Molly Eisner listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.